Skip to main content
Article
Early intervention in schizophrenia: three frameworks for guiding ethical inquiry
Systems and Psychosocial Advances Research Center Publications and Presentations
  • Philip J. Candilis, University of Massachusetts Medical School
UMMS Affiliation
Department of Psychiatry
Date
12-1-2003
Document Type
Article
Medical Subject Headings
*Bioethical Issues; Biomedical Research; Clinical Trials as Topic; Humans; Risk Factors; Schizophrenia
Abstract
Psychiatric research is making important strides toward early detection and treatment of schizophrenia. Discovery of genetic markers, identifiable prodromes, and low-risk interventions fuel this vital scientific movement. At the same time, investigators and clinicians are studying the ethical questions that arise whenever the bounds of diagnosis and treatment are evolving rapidly. This ethical analysis generally falls within three dominant frameworks of bioethics: the conceptualization of disease, scientific uncertainty, and risk-factor ethics. These frameworks are explored as potential guides for directing ethical inquiry in early intervention.
Rights and Permissions
Citation: Psychopharmacology (Berl). 2003 Dec;171(1):75-80. Epub 2003 Mar 25. Link to article on publisher's site
Related Resources
Link to Article in PubMed
PubMed ID
14654998
Citation Information
Philip J. Candilis. "Early intervention in schizophrenia: three frameworks for guiding ethical inquiry" Vol. 171 Iss. 1 (2003) ISSN: 0033-3158 (Linking)
Available at: http://works.bepress.com/philip_candilis/5/